IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ASCIONE, LILIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 861
EU - Europa 651
NA - Nord America 524
SA - Sud America 112
AF - Africa 25
OC - Oceania 3
Totale 2.176
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 503
SG - Singapore 280
CN - Cina 269
DE - Germania 252
IT - Italia 122
HK - Hong Kong 95
VN - Vietnam 93
BR - Brasile 86
FR - Francia 62
RU - Federazione Russa 52
SE - Svezia 40
IN - India 38
FI - Finlandia 32
NL - Olanda 32
BD - Bangladesh 25
GB - Regno Unito 18
CI - Costa d'Avorio 14
TR - Turchia 13
AR - Argentina 12
CA - Canada 12
JP - Giappone 7
KR - Corea 7
AT - Austria 6
EC - Ecuador 6
ES - Italia 6
ID - Indonesia 6
IE - Irlanda 6
PL - Polonia 6
SA - Arabia Saudita 6
MX - Messico 5
IQ - Iraq 3
LB - Libano 3
VE - Venezuela 3
ZA - Sudafrica 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
MA - Marocco 2
MY - Malesia 2
PS - Palestinian Territory 2
RO - Romania 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GU - Guam 1
IL - Israele 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
RW - Ruanda 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 2.176
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 219
Singapore 125
Ashburn 124
Hefei 82
Hong Kong 78
San Jose 48
Dallas 45
Council Bluffs 43
Milan 35
Beijing 32
Hanoi 29
Boardman 25
Bengaluru 23
Ho Chi Minh City 23
Santa Clara 23
Helsinki 20
Los Angeles 19
Lauterbourg 18
Buffalo 16
Moscow 15
Abidjan 14
New York 13
Munich 12
Chicago 11
Istanbul 10
São Paulo 9
Düsseldorf 8
Lappeenranta 8
Rome 7
Da Nang 6
Dublin 6
Guangzhou 6
Nuremberg 6
Seoul 6
Tokyo 6
Buenos Aires 5
Mumbai 5
Shanghai 5
Bexley 4
Brooklyn 4
Hyderabad 4
Palermo 4
Turku 4
Amsterdam 3
Can Tho 3
Cangzhou 3
Changsha 3
Columbus 3
Dhaka 3
Fuzhou 3
Johannesburg 3
Montreal 3
Paris 3
Porto Alegre 3
Seattle 3
Shenzhen 3
Vienna 3
Wuhan 3
Amman 2
Ankara 2
Atlanta 2
Baicheng 2
Bari 2
Bergamo 2
Biên Hòa 2
Bologna 2
Brembate di Sopra 2
Bucharest 2
Bắc Ninh 2
Bến Tre 2
Calgary 2
Charlotte 2
Cleveland 2
Cologne 2
Florence 2
Foshan 2
Go Vap 2
Goiânia 2
Greensboro 2
Hangzhou 2
Jakarta 2
Legnano 2
Livorno 2
Lodi 2
Lomas de Zamora 2
London 2
Lumezzane 2
McAllen 2
Moncalieri 2
Mornico al Serio 2
Naples 2
Pelotas 2
Phoenix 2
Prague 2
Quanzhou 2
Rancho Palos Verdes 2
Reggio Emilia 2
Riobamba 2
Riyadh 2
Salt Lake City 2
Totale 1.334
Salva come PNG Salva come JPEG
Nome #
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 200
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 191
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives 164
Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy 150
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience 138
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection 137
Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases 126
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 121
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population 118
Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives 117
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit 114
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience 108
Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer 105
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology 99
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens’ Targetability 98
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls 95
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative 86
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers 83
Pembrolizumab and oral metronomic cyclophosphamide in patients with chest wall breast cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1) 3
Totale 2.253
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024178 7 0 1 11 7 9 24 25 10 19 28 37
2024/2025563 38 35 32 34 26 11 6 57 43 71 76 134
2025/20261.512 202 199 197 153 104 59 179 52 147 96 124 0
Totale 2.253